CORRECTING and REPLACING -- Accolade To Present at Upcoming Investor Conferences
06 sept. 2023 14h08 HE
|
Accolade, Inc.
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Sept. 5, 2023 by Accolade, Inc. (NASDAQ: ACCD), please note that in the second bullet, the time of the...
Accolade To Present at Upcoming Investor Conferences
05 sept. 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming...
Accolade Announces Results for Fiscal First Quarter 2024
29 juin 2023 16h03 HE
|
Accolade, Inc.
Accolade exceeds guidance for fiscal first quarter and raises guidance for fiscal year 2024 SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial...
Accolade to Announce Fiscal First Quarter 2024 Financial Results
13 juin 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, June 13, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal first quarter 2024...
Accolade To Present at Stifel 2023 Cross Sector Insight Conference
01 juin 2023 11h04 HE
|
Accolade, Inc.
SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stifel 2023 Cross...
Accolade Announces Upcoming Investor Events
08 mai 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, May 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the following upcoming...
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2023
27 avr. 2023 16h03 HE
|
Accolade, Inc.
Fiscal fourth quarter 2023 revenue of $99.0 million, a 6% increase compared to fiscal fourth quarter 2022 revenue of $93.8 million Fiscal year 2023 revenue of $363.1 million, a 17% increase compared...
Accolade to Webcast Analyst Day on May 8, 2023
24 avr. 2023 16h05 HE
|
Accolade, Inc.
SEATTLE, April 24, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will host an Analyst Day at the Wynn Las...
Accolade to Announce Fiscal Fourth Quarter 2023 Financial Results
11 avr. 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal fourth quarter 2023...
Michael Hilton Joins Accolade Board of Directors
16 févr. 2023 08h00 HE
|
Accolade, Inc.
SEATTLE, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced changes to its Board of Directors. The Company announced today that long-time executive Michael Hilton will...